Johnson & Johnson Assets & Liabilities Overview 2006-2018 | JNJ

Current and historical assets & liabilities overview for Johnson & Johnson (JNJ) from 2006 to 2018.
Johnson & Johnson Annual Assets & Liabilities Overview
(Millions of US $)
Johnson & Johnson Quarterly Assets & Liabilities Overview
(Millions of US $)
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $344.163B $76.450B
Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin care, oral care, wound care, and women's health fields, nutritional and over-the-counter pharmaceutical products. The company's Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, thrombosis, vaccines, and infectious diseases. Its Medical Devices and Diagnostics segment offers electrophysiology and circulatory disease management products; orthopaedic joint reconstruction, spinal care, neurological, and sports medicine products; surgical care, aesthetics, and women's health products. Johnson & Johnson is based in New Brunswick, New Jersey.
Stock Name Country Market Cap PE Ratio
Pfizer (PFE) United States $252.223B 14.22
Novartis AG (NVS) Switzerland $200.554B 17.19
Merck (MRK) United States $197.819B 17.14
AbbVie (ABBV) United States $127.497B 11.32
Eli Lilly (LLY) United States $121.483B 21.36
Novo Nordisk (NVO) Denmark $113.991B 18.51
Sanofi (SNY) France $104.462B 12.94
GlaxoSmithKline (GSK) United Kingdom $95.776B 12.87
AstraZeneca (AZN) United Kingdom $90.044B 11.18
Bristol-Myers Squibb (BMY) United States $78.297B 12.90